FOXO TECHNOLOGIES INC. Increase (Decrease) in Accounts Payable
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Accounts Payable of $896.10 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $399.98K.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $496.13K, a 22.29% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $207.02K.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$372.10K, a 184.87% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for fiscal 2025 was $186.25K, a 83.91% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for fiscal 2024 was $1.16M, a 133.47% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for fiscal 2023 was $495.76K, a 290.36% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts payable for fiscal 2022 was $127.00K, a 95.89% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $399.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $896.10K 10-Q · filed 2026-08-14 | $1.10M derived: sum of 3 quarters · filed 2026-08-14 | $731.02K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $496.13K 10-Q · filed 2026-05-15 | $703.15K derived: sum of 2 quarters · filed 2026-05-15 | $331.04K derived: sum of 3 quarters · filed 2026-05-15 | $43.92K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $207.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$165.09K derived: sum of 2 quarters · filed 2026-04-15 | -$452.21K derived: sum of 3 quarters · filed 2026-08-14 | $186.25K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$372.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$659.23K derived: sum of 2 quarters · filed 2026-08-14 | -$20.77K 10-Q · filed 2025-11-10 | -$372.22K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$287.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $351.34K 10-Q · filed 2026-08-14 | -$119.00 derived: sum of 3 quarters · filed 2026-08-14 | $438.30K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $638.46K 10-Q · filed 2026-05-15 | $287.00K derived: sum of 2 quarters · filed 2026-05-15 | $725.42K derived: sum of 3 quarters · filed 2026-05-15 | $813.38K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$351.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $86.97K derived: sum of 2 quarters · filed 2026-04-15 | $174.91K derived: sum of 3 quarters · filed 2026-04-15 | $1.16M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $438.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $526.37K derived: sum of 2 quarters · filed 2025-11-10 | $1.51M 10-Q · filed 2025-11-10 | $1.51M 10-Q · filed 2024-11-19 | $198.66K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $87.95K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $1.07M 10-Q · filed 2025-08-19 | $1.17M 10-Q · filed 2024-08-19 | -$239.76K derived: sum of 3 quarters · filed 2025-08-19 | $1.01M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | $982.53K 10-Q/A · filed 2025-08-19 | $983.00K 10-Q · filed 2024-06-28 | -$327.71K derived: sum of 2 quarters · filed 2025-08-19 | $923.29K derived: sum of 3 quarters · filed 2025-08-19 | $1.97M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$59.24K derived: sum of 2 quarters · filed 2025-04-15 | $984.76K derived: sum of 3 quarters · filed 2025-04-15 | $495.76K 10-K · filed 2025-04-15 | $1.30M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $2.29M derived: sum of 2 quarters · filed 2024-11-19 | $1.81M 10-Q · filed 2024-11-19 | $2.42M derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $555.00K 10-Q · filed 2024-08-19 | $1.17M derived: sum of 3 quarters · filed 2024-08-19 | $2.33M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | -$489.00K 10-Q · filed 2024-06-28 | $127.00K derived: sum of 2 quarters · filed 2024-06-28 | $1.28M derived: sum of 3 quarters · filed 2024-06-28 | $1.85M derived: sum of 4 quarters · filed 2024-06-28 | ||||
| 2022-12-31 | $616.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $1.77M derived: sum of 2 quarters · filed 2024-06-06 | $2.34M derived: sum of 3 quarters · filed 2024-06-06 | $127.00K 10-K · filed 2024-06-06 | ||||
| 2022-09-30 | $1.16M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $1.72M derived: sum of 2 quarters · filed 2024-06-04 | -$489.00K 10-Q/A · filed 2024-06-04 | $354.00K derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | $563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.65M 10-Q · filed 2023-08-10 | -$803.00K derived: sum of 3 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$2.21M 10-Q · filed 2023-05-11 | -$1.37M derived: sum of 2 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | $843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.09M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | $2.25M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |